Study | MDD Ax Yes/No (method) | Depression severity at baseline m | Participant ethnicity n, % | Sample n | Recruitment setting | Control condition | Depression outcome measure, time points | Country | LMIC Country m |
---|---|---|---|---|---|---|---|---|---|
Alhusen et al. [87] | No | Moderate | African American 54, 90.0% | 60 | Clinical | TAU | EPDS, PI, 3 MFU | USA | No |
White 6, 10.0% | |||||||||
Ammerman et al. [88] | Yes (SCID) | Severe | Race | 93 | Clinical | TAU | EPDS, PI, 3 MFU | USA | No |
White 58, 62.4% | |||||||||
African American 30, 32.3% | |||||||||
Native American 1, 1.1% | |||||||||
Native Hawaiian or other Pacific Islander 2, 2.2% | |||||||||
Bi-racial 2, 2.2% | |||||||||
Ethnicity | |||||||||
Latina 7, 7.5% | |||||||||
None 86, 92.5% | |||||||||
Burns et al. [89] | Yes (CIS-R) | Moderate | Ethnicity | 36 | Clinical | TAU | EPDS, PI, 4 MFU | UK | No |
White 30, 83.3% | |||||||||
Dimidjian et al. [90] | No | Moderate | Race | 163 | Clinical | TAU | PHQ-9, PI | USA | No |
White 95, 58.3% | |||||||||
Black 45, 27.6% | |||||||||
Asian 7, 4.3% | |||||||||
Other 16, 9.8% | |||||||||
Hispanic ethnicity | |||||||||
25, 15.3% | |||||||||
Forsell et al. [91] | Yes (SCID) | Moderate | NI | 42 | Mixed | TAU | MADRS-S, PI | Sweden | No |
Fuhr et al. [92] | No | Moderate | NI | 280 | Clinical | Enhanced TAU | PHQ-9, PI, 3 MFU | India | Yes |
Honey et al. [85] | No | Moderate | NI | 45 | Clinical | TAU | EPDS, PI, 6 MFU | UK | No |
Hughes et al. [32] | Yes (SCID) CO | Moderate | White 14, 20.0% | 70 | Clinical | TAU | EPDS, PI, 3 MFU | USA | No |
Black 10, 14.3% | |||||||||
Hispanic 41, 58.6% | |||||||||
Other 5, 7.1% | |||||||||
Khamseh et al. [83] | No | Mild | NI | 70 | Clinical | TAU | BDI-II, PI, 1 MFU | Iran | Yes |
Lund et al. [93] | Yes (MINI) | Mild | NI | 425 | Clinical | Enhanced TAU | HDRS, PI, 9 MFU | South Africa | Yes |
McKee et al. [86]a | No | Moderate | Black 81, 43.3% | 187 | Clinical | TAU | BDI-II, PI | USA | No |
Hispanic 106, 56.7% | |||||||||
Meager & Milgrom, [84]a | No | Severe | Australian born 16, 80.0% | 20 | Clinical | WLC | EPDS, PI | Australia | No |
From Ireland, Scotland and the United Kingdom 4, 20.0% | |||||||||
Milgrom et al. [94] | Yes (CIDI) screening | Moderate | NI | 192 | Clinical | TAU | BDI-II, PI | Australia | No |
Milgrom et al. [73] | No | Moderate | Born in Australia 56, 82.4% | 68 | Clinical | Enhanced TAU | BDI-II, PI | Australia | No |
Milgrom et al. [95] A | Yes (SCID) screening | Severe | Born in Australia 42, 77.8% | 54 | Clinical | TAU | BDI-II, PI, 11 MFU | Australia | No |
Milgrom et al., [96] B | Yes (CIDI) screening | Severe | NI | 45 | Clinical | AC | BDI-II, PI, 3 MFU | Australia | No |
Milgrom et al., [97] | Yes (SCID) | Moderate | Born in Australia 39, 90.7% | 43 | Mixed | TAU | BDI-II, PI | Australia | No |
Misri et al. [98] | No | Moderate | White 22, 62.9% | 35 | Clinical | AC | EPDS, PI | Canada | No |
South Asian 5, 14.3% | |||||||||
First Nations 3, 8.6% | |||||||||
Mexican 1, 2.9% | |||||||||
Spanish 1, 2.9% | |||||||||
Indo-Canadian 1, 2.9% | |||||||||
Italian 1, 2.9% | |||||||||
South American 1, 2.9% | |||||||||
Morrell et al. [99] | No | Unknown | White British 390, 93.3% | 418 | Clinical | TAU | EPDS, PI | UK | No |
Nasiri et al. [100] | No | Moderate | NI | 120 | Clinical | TAU | BDI-II, PI | Iran | Yes |
Ngai et al. [101]a | No | NI | NI | 397 | Clinical | TAU | EPDS, PI, 6 MFU | Hong Kong | No |
O’Mahen et al. [102]A | Yes (SCID) screening | Moderate | African American 32, 58.2% | 55 | Clinical | TAU | BDI-II, PI, 3 MFU | USA | No |
White 17, 30.9% | |||||||||
Asian 4, 7.3% | |||||||||
Other 2, 3.6% | |||||||||
O’Mahen et al. [103]B | No | Severe | NI | 910 | Internet | TAU | EPDS, PI | UK | No |
O’Mahen et al. [104] | Yes (CIS-R) screening | Severe | White/British 77, 92.8% | 83 | Internet | TAU | EPDS, PI, 6 MFU | UK | No |
Asian 1, 1.2% | |||||||||
Mixed white/African/Caribbean 2, 2.4% | |||||||||
African 1, 1.2% | |||||||||
Other 2, 2.4% | |||||||||
Pugh et al. [105] | YES (MINI) screening only | Moderate | Caucasian 45, 95.7% | 47 | Mixed | WLC | EPDS, PI | Canada | No |
Other 2, 4.3% | |||||||||
Rojas et al. [106] | YES (MINI) screening | Moderate | NI | 230 | Clinical | Enhanced TAU | EPDS, PI, 3 MFU | Chile | No |
Sikander et al. [107] | No | Moderate | NI | 570 | Community | Enhanced TAU | PHQ-9, PI, 3 MFU | Pakistan | Yes |
Trevillion et al. [108] | YES (SCID) | NI | White 35, 66.0% | 53 | Mixed | TAU | EPDS, PI, 3 MFU | UK | No |
Black: 14, 26.4% | |||||||||
Asian: 1, 1.9% | |||||||||
Mixed/Other: 3, 5.7% | |||||||||
Van Lieshout et al. [109] | No | Moderate | White 291, 72.2% | 403 | Mixed | TAU | EPDS, PI | Canada | No |
Wiklund et al. [110]a | No | Moderate | Born in Sweden 61, 91.0% | 67 | Clinical | TAU | EPDS, PI | Sweden | No |
Wozney et al. [111]a | Yes (SCID) | Moderate | NI | 62 | Mixed | TAU | EPDS, PI, 6 & 12 MFU | Canada | No |